Fabricante de polvo de esteroides anabólicos de China
EnglishAfrikaansБългарскиNederlandsFrançaisDeutschItaliano日本語LatīnaNorskپارسیPolskiPortuguêsRomânăРусскийSlovenčinaSlovenščinaEspañolSvenskaTürkçeУкраїнськаудмурт кыл

Fármacos anestésicos locales

» productos farmaceuticos » Fármacos anestésicos locales

  • Presupuesto
  • Descripción del producto
  • Uso del producto
  • COA

nombre del producto: lidocaína
Another Name: Xylocaine
CAS:137-58-6
FM:C14H22N2O
megavatios:234.34
Ensayo:99%
Apariencia: polvo blanco
Uso:can be used to relieve pain

lidocaína, xylocaine, or lignocaine is a common local anesthetic and class-1b antiarrhythmic drug. Lidocaine is used topically to relieve itching, burning, and pain from skin inflammations, injected as a dental anesthetic, or as a local anesthetic for minor surgery.It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic healthcare system.

Lidocaine is the most important class-1b antiarrhythmic drug; it is used intravenously for the treatment of ventricular arrhythmias (for acute myocardial infarction, digoxin poisoning, cardioversion, or cardiac catheterization) if amiodarone is not available or contraindicated.

Lidocaine should be given for this indication after defibrillation, CPR, and vasopressors have been initiated. A routine prophylactic administration is no longer recommended for acute cardiac infarction; the overall benefit of this measure is not convincing.

The efficacy profile of lidocaine as a local anesthetic is characterized by a rapid onset of action and intermediate duration of efficacy. Therefore, lidocaine is suitable for infiltration, block, and surface anesthesia. Longer-acting substances such as bupivacaine are sometimes given preference for subdural and epidural anesthesias; lidocaine,though, has the advantage of a rapid onset of action.

Relative insensitivity to lidocaine is genetic.In hypokalemic sensory overstimulation, relative insensitivity to lidocaine has been described in people who also have attention deficit hyperactivity disorder.In dental anesthesia, a relative insensitivity to lidocaine can occur for anatomical reasons due to unexpected positions of nerves. Some people with Ehlers-Danlos syndrome are insensitive to lidocaine.

lidocaína, along with ethanol, ammonia, and acetic acid, has also been proven to be effective in treating jellyfish stings, both numbing the affected area and preventing further nematocyst discharge.

Items Tested Especificación BP2007 Resultado
Caracteres White or slightly yellow crystal powder with characteristic odor White crystal powder with weak odor
Punto de fusion Punto de fusion: 66 degree to 70 degree 66.6 degree-68.5 degree
Identificación BCDE
Comply with the requirement
conforme
Appearance of solution Clear and colorless conforme
Agua Not more than 0.5% 0.3%
Sulphate Not more than0. 1% conforme
Chloride Not more than 0. 0035% 0.0025%
Heavy Metals Not more than 0.002% 0.001%
Residue on Ignition Not more than 0.1% 0.02%
Impureza
(26-dimethylaniline content)
Not more than 0.01% conforme
Ensayo (HPLC) 99.0%-101.0% 99.50%

Formulario de Consulta ( vamos a ayudarle a volver tan pronto como sea posible )

Nombre:
*
Email:
*
Mensaje:

Verificación:
5 + 5 = ?

Tal vez como también

  • Nuestra ventaja

    Buen precio

    Alta calidad

    Entrega rápida

    Envío seguro

    Excelente servicio postventa

  • Almacén Local

    Almacén de la UE

    Almacén del Reino Unido

    Almacén de EE. UU.

    Almacén de Canadá

    Australia almacén

  • Método de pago

    PayPal

    Bitcoin

    Transferencia bancaria

    Pago de Pequeña Cantidad

    Western Union

  • Contáctenos

    Email: jacob@steroid-peptide.com

    WhatsApp: +8615636286252

    Teléfono: 0086-15636286252

    Sitio web: www.esteroides-péptidos.com

    Bienvenido a su consulta

  • Servicio